Get started
Author

Bryan Wahking

Observed names: B Wahking, Wahking, Bryan
Observed institution: Johnson & Johnson (Singapore)
ORCID: 0000-0001-6016-8209
Observed ORCID: 0000-0001-6016-8209
OpenAlex ID: A5070782455
Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region
2021 · Yayoi Tada, Seong Jin Jo, et al. · The Journal of Dermatology · 16
Persistence of advanced therapies in patients with inflammatory bowel disease: retrospective cohort study using a large healthcare claims database in Japan
2024 · Katsuyoshi Matsuoka, Ko Nakajo, et al. · Intestinal Research · 13
Elevating the role of carers in rheumatoid arthritis management in the Asia‐Pacific region
2020 · Kevin Pile, Rachel Norager, et al. · International Journal of Rheumatic Diseases · 8
PDF
Guselkumab in East Asians With Moderate‐to‐Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies
2025 · Baili Chen, Byong Duk Ye, et al. · Journal of Gastroenterology and Hepatology · 7
PDF
Warm Autoimmune Haemolytic Anaemia Management in Asia‐Pacific: A Delphi Panel Expert Consensus and Systematic Literature Review
2025 · Phil Choi, Alberta Hoi, et al. · eJHaem · 2
PDF
Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the Phase 3 GRAVITI study
2026 · Wenjia Liu, Hong Guo, et al. · Intestinal Research · 1
PDF
Efficacy and Safety of Ustekinumab in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Subpopulation Analysis of UNIFI Long-Term Extension through 4 Years
2025 · Hyo Jong Kim, Satoshi Motoya, et al. · Inflammatory Intestinal Diseases · 1
PDF
Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years
2026 · Byong Duk Ye, Ken Sugimoto, et al. · Intestinal Research
PDF
77535 Clinical Outcomes of Guselkumab in Biologic-Naïve Psoriasis Patients with Short and Long Disease Durations: A Real-world Study in Taiwan
2026 · Grace Hui-Min Wu, Shu-chen Chang, et al. · Journal of the American Academy of Dermatology
Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials
2026 · Hiroshi Nakase, Baili Chen, et al. · Intestinal Research
PDF
Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan
2026 · Youran Xu, Tong Li, et al. · Psoriasis Targets and Therapy
PDF
Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan
2026 · Yu-Huei Huang, Youran Xu, et al. · Journal of Dermatological Treatment
Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan
2026 · Huang, Yu-Huei, Xu, Youran, et al. · Figshare
P1030 Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn’s disease: Subgroup analysis of the Phase 3 GRAVITI study
2025 · W Liu, H Guo, et al. · Journal of Crohn s and Colitis
PDF
P0976 Guselkumab efficacy and safety in East Asian participants with moderate to severely active Crohn’s disease: Subgroup analysis of the GALAXI 2 & 3 Phase 3 studies
2025 · H Nakase, B Chen, et al. · Journal of Crohn s and Colitis
P1141 Guselkumab efficacy and safety in East Asian participants with moderate to severely active Ulcerative Colitis: Subgroup analysis of the Phase 2b/3 QUASAR induction and maintenance studies
2025 · B Chen, B D Ye, et al. · Journal of Crohn s and Colitis
PDF
Tu1820 PERSISTENCE OF ADVANCED THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE COHORT STUDY USING LARGE HEALTHCARE CLAIMS DATABASE IN JAPAN
2024 · Katsuyoshi Matsuoka, Shiho Kawamura, et al. · Gastroenterology
P1187 Persistence of Advanced Therapies in Patients with Inflammatory Bowel Disease: Retrospective cohort study using large healthcare claims database in Japan
2024 · K Matsuoka, S Kawamura, et al. · Journal of Crohn s and Colitis
PDF
Works count: 18
Citation count: 48
H-index: 4
I10-index: 2
Year
Topic
Type